ERBB2 and breast carcinoma: Based on these results, the National Comprehensive Cancer Network guidelines recommend strong consideration of the 21-gene RS assay to determine the adjuvant chemotherapy in patients with tumor size > 0.5 cm, N0, and HR-positive/HER2-negative breast cancer [12].